1![DOI: aimdrCase Report ISSN (O):; ISSN (P): DOI: aimdrCase Report ISSN (O):; ISSN (P):](https://www.pdfsearch.io/img/1418fbd095f3e46de4d24de514e06532.jpg) | Add to Reading ListSource URL: aimdrjournal.comLanguage: English - Date: 2016-06-18 07:17:23
|
---|
2![Metronidazole IV Shortage Currently marketed formulations of metronidazole IV1 DIN[removed]Company Metronidazole IV Shortage Currently marketed formulations of metronidazole IV1 DIN[removed]Company](https://www.pdfsearch.io/img/c941dfcb456c0726b9122402854d7d24.jpg) | Add to Reading ListSource URL: medsask.usask.caLanguage: English - Date: 2014-11-04 15:10:35
|
---|
3![8EHQ-10-17365E TSCA 8(e) Notice 8EHQ-10-17365E TSCA 8(e) Notice](https://www.pdfsearch.io/img/a9397ba65979b77f7411edb9b2a9cfaa.jpg) | Add to Reading ListSource URL: www.epa.govLanguage: English - Date: 2012-07-24 13:54:38
|
---|
4![8EHQ-10-17365E TSCA 8(e) Notice 8EHQ-10-17365E TSCA 8(e) Notice](https://www.pdfsearch.io/img/d41862edf75d0586f560e47b92030c9d.jpg) | Add to Reading ListSource URL: www.epa.govLanguage: English - Date: 2012-07-24 13:54:38
|
---|
5![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use METROGEL (metronidazole) Gel, 1% safely and effectively. See full prescribing information for METROGEL HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use METROGEL (metronidazole) Gel, 1% safely and effectively. See full prescribing information for METROGEL](https://www.pdfsearch.io/img/b790b225e69fbe3be9bb8ac4564698eb.jpg) | Add to Reading ListSource URL: www.metrogel.comLanguage: English - Date: 2013-09-20 10:57:50
|
---|
6![Clinical Features: (symptoms, complications) Clinical Features: (symptoms, complications)](https://www.pdfsearch.io/img/11cb3644759db9ce4e6409e9424be3ef.jpg) | Add to Reading ListSource URL: www.kdheks.govLanguage: English - Date: 2012-09-20 15:11:32
|
---|
7![DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Silver Spring, MD 20993 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Silver Spring, MD 20993](https://www.pdfsearch.io/img/be40e994f3d6b4dffc9947b5f0b0b668.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
8![Peroxynitrite and Peroxiredoxin in the Pathogenesis of Experimental Amebic Liver Abscess Peroxynitrite and Peroxiredoxin in the Pathogenesis of Experimental Amebic Liver Abscess](https://www.pdfsearch.io/img/fb06b823859ea5047d44f64e89ce18cf.jpg) | Add to Reading ListSource URL: www.ncbi.nlm.nih.govLanguage: English |
---|
9![A longitudinal study of stavudine-associated toxicities in a large cohort of South African HIV infected subjects A longitudinal study of stavudine-associated toxicities in a large cohort of South African HIV infected subjects](https://www.pdfsearch.io/img/de655ed57c9673e1c8b49e853493253e.jpg) | Add to Reading ListSource URL: www.ncbi.nlm.nih.govLanguage: English |
---|
10![Entamoeba histolytica and E. dispar Calreticulin: Inhibition of Classical Complement Pathway and Differences in the Level of Expression in Amoebic Liver Abscess Entamoeba histolytica and E. dispar Calreticulin: Inhibition of Classical Complement Pathway and Differences in the Level of Expression in Amoebic Liver Abscess](https://www.pdfsearch.io/img/a7dae8bea17c03197f30e232a01f651a.jpg) | Add to Reading ListSource URL: www.ncbi.nlm.nih.govLanguage: English |
---|